Vaginal hysterectomy for uterovaginal prolapse: what is the incidence of concurrent gynecological malignancy?

Risk of malignancy in women who underwent hysterectomy for uterine prolapse

(2013) Osanna Y. K. Wan et al.   AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY

Staging classification for cancer of the ovary, fallopian tube, and peritoneum

(2013) Jaime Prat et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Translation and psychometric evaluation of the Greek short forms of two condition-specific quality of life questionnaires for women with pelvic floor disorders: PFDI-20 and PFIQ-7

(2013) Themos Grigoriadis et al.   INTERNATIONAL UROGYNECOLOGY JOURNAL

The vaginally assisted laparoscopic sacrocolpopexy: a pilot study

(2012) Stavros Athanasiou et al.   INTERNATIONAL UROGYNECOLOGY JOURNAL

Capacity of endometrial thickness measurement to diagnose endometrial carcinoma in asymptomatic postmenopausal women: a systematic review and meta-analysis

(2012) M. C. Breijer et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Risk of unanticipated abnormal gynecologic pathology at the time of hysterectomy for uterovaginal prolapse

(2010) Anna C. Frick et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Uterus conserving prolapse surgery—what is the chance of missing a malignancy?

(2010) Arasee Renganathan et al.   INTERNATIONAL UROGYNECOLOGY JOURNAL

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

(2009) Usha Menon et al.   LANCET ONCOLOGY